<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03622489</url>
  </required_header>
  <id_info>
    <org_study_id>0022-17-WOMC</org_study_id>
    <nct_id>NCT03622489</nct_id>
  </id_info>
  <brief_title>Comparing Protocols for Analgesia Following Elective Cesarean Section</brief_title>
  <official_title>Comparing Protocols for Analgesia Following Elective Cesarean Section</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Wolfson Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Wolfson Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Women undergoing elective cesarian section will be assigned to 3 groups for postoperative
      analgesia:

        1. Scheduled doses of IV acetaminophen + PO Ibuprofen

        2. Scheduled doses of PO acetaminophen + PO Ibuprofen

        3. &quot;On demand&quot; doses of acetaminophen, dipyrone and ibuprofen.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A prospective randomised trial. Women undergoing elective cesarean section will be randomized
      to three groups. The treatment will be given for 48 hours after surgery. For evealuating
      objective pain sensation the investigators will be using the Visual Numerical Score (VNS).
      Demographic characteristics and information about breastfeeding and medications' side
      effects, will be reviewed from patients' medical scores.

      Exclusion criteria: known allergies to one or more of the studies' drugs, general anesthesia,
      woman undergoing her 3rd cesarean section or more, elective tubal ligation performed at the
      time of current cesarean section, contraindication for use of one or more of the studies'
      drugs.

      Number of participants: 120

      Treatment:

      All women will receive immediately after surgery, in the recovery room:

        1. IV morphin 5 mg, repeat doses every 10 minutes for VNS&gt;3

        2. IV Tramal 100 mg, once

      After Admitted to Mternity ward:

        -  1st group will be receiving scheduled doses: 08:00 hr, Tab. Ibuprofen 400 mg, and IV
           Acetaminophen 1 gr 14:00 hr, IV Acetaminophen 1 gr 19:00 hr, Tab. Ibuprofen 400 mg 00:00
           hr, IV Acetaminophen 1 gr

        -  2nd group will be receiving scheduled doses: 08:00 hr, Tab. Ibuprofen 400 mg, and PO
           Acetaminophen 1 gr 14:00 hr, PO Acetaminophen 1 gr 19:00 hr, Tab. Ibuprofen 400 mg 00:00
           hr, PO Acetaminophen 1 gr

        -  1st+2nd group will be given additional analgesia if needed according to VNS scale: PO
           drops Dipyrone 1 gr, for VNS&gt;4, up to 4 times a day, at least 6 hours between doses.

      Tab Tramadex 100 mg, for VNS&gt;6, or if pain persists for 1 hour after receiving Dipyrone, up
      to 3 times a day, at least 4 hours between doses.

      - 3rd group will not receive scheduled pain medication, but offered some only upon patients'
      request according to VNS score:

        -  Tab. Acetaminophen 1 gr, for VNS 1-3, up to 4 times a day, at east 6 hours between
           doses.

        -  PO drops Dipyrone 1 gr, for VNS 4-7, or if pain persists for 1 hour after receiving
           Acetaminophen, up to 4 times a day, at least 6 hours between doses.

        -  Tab Ibuprofen 400 mg, for VNS 8-10, or if pain persists for 1 hour after receiving
           Dipyrone, up to 3 times a day, at least 8 hours between doses.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date type="Actual">March 1, 2017</start_date>
  <completion_date type="Anticipated">August 31, 2018</completion_date>
  <primary_completion_date type="Anticipated">August 31, 2018</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Average pain score 48 hours following surgery: visual numerical scale (VNS)</measure>
    <time_frame>48 hours</time_frame>
    <description>Using : visual numerical scale (VNS)</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Postoperative Pain</condition>
  <condition>Post-Cesarean Section</condition>
  <arm_group>
    <arm_group_label>Tab ibuprofen + IV acetaminophen</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>All women will receive immediately after surgery, in the recovery room:
IV morphin 5 mg, repeat doses every 10 minutes for VNS&gt;3
IV Tramal 100 mg, once
After Admitted to Maternity ward:
- Scheduled doses: 08:00 hr, Tab. Ibuprofen 400 mg, and IV Acetaminophen 1 gr 14:00 hr, IV Acetaminophen 1 gr 19:00 hr, Tab. Ibuprofen 400 mg 00:00 hr, IV Acetaminophen 1 gr
-Additional analgesia if needed according to VNS scale: PO drops Dipyrone 1 gr, for VNS&gt;4, up to 4 times a day, at least 6 hours between doses.
Tab Tramadex 100 mg, for VNS&gt;6, or if pain persists for 1 hour after receiving Dipyrone, up to 3 times a day, at least 4 hours between doses.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Tab Ibuprofen + Tab acetaminophen</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>All women will receive immediately after surgery, in the recovery room:
IV morphin 5 mg, repeat doses every 10 minutes for VNS&gt;3
IV Tramal 100 mg, once
After Admitted to Maternity ward:
- Scheduled doses: 08:00 hr, Tab. Ibuprofen 400 mg, and PO Acetaminophen 1 gr 14:00 hr, PO Acetaminophen 1 gr 19:00 hr, Tab. Ibuprofen 400 mg 00:00 hr, PO Acetaminophen 1 gr
- Additional analgesia if needed according to VNS scale: PO drops Dipyrone 1 gr, for VNS&gt;4, up to 4 times a day, at least 6 hours between doses.
Tab Tramadex 100 mg, for VNS&gt;6, or if pain persists for 1 hour after receiving Dipyrone, up to 3 times a day, at least 4 hours between doses.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>&quot;On demand&quot; analgesia</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>All women will receive immediately after surgery, in the recovery room:
IV morphin 5 mg, repeat doses every 10 minutes for VNS&gt;3
IV Tramal 100 mg, once
After Admitted to Mternity ward:
Will not receive scheduled pain medication, but offered some only upon patients' request according to VNS score:
Tab. Acetaminophen 1 gr, for VNS 1-3, up to 4 times a day, at east 6 hours between doses.
PO drops Dipyrone 1 gr, for VNS 4-7, or if pain persists for 1 hour after receiving Acetaminophen, up to 4 times a day, at least 6 hours between doses.
Tab Ibuprofen 400 mg, for VNS 8-10, or if pain persists for 1 hour after receiving Dipyrone, up to 3 times a day, at least 8 hours between doses.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Acetaminophen</intervention_name>
    <description>mentioned above</description>
    <arm_group_label>&quot;On demand&quot; analgesia</arm_group_label>
    <arm_group_label>Tab Ibuprofen + Tab acetaminophen</arm_group_label>
    <arm_group_label>Tab ibuprofen + IV acetaminophen</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ibuprofen 400 mg</intervention_name>
    <description>mentioned above</description>
    <arm_group_label>&quot;On demand&quot; analgesia</arm_group_label>
    <arm_group_label>Tab Ibuprofen + Tab acetaminophen</arm_group_label>
    <arm_group_label>Tab ibuprofen + IV acetaminophen</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dipyrone</intervention_name>
    <description>mentioned above</description>
    <arm_group_label>&quot;On demand&quot; analgesia</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Tramadol</intervention_name>
    <description>mentioned above</description>
    <arm_group_label>&quot;On demand&quot; analgesia</arm_group_label>
    <arm_group_label>Tab Ibuprofen + Tab acetaminophen</arm_group_label>
    <arm_group_label>Tab ibuprofen + IV acetaminophen</arm_group_label>
    <other_name>Tramadex</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Morphine</intervention_name>
    <description>mentioned above</description>
    <arm_group_label>&quot;On demand&quot; analgesia</arm_group_label>
    <arm_group_label>Tab Ibuprofen + Tab acetaminophen</arm_group_label>
    <arm_group_label>Tab ibuprofen + IV acetaminophen</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Tramal</intervention_name>
    <description>mentioned above</description>
    <arm_group_label>&quot;On demand&quot; analgesia</arm_group_label>
    <arm_group_label>Tab Ibuprofen + Tab acetaminophen</arm_group_label>
    <arm_group_label>Tab ibuprofen + IV acetaminophen</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Women undergoing elective cesarian section

        Exclusion Criteria:

          -  known allergies to one or more of the studies' drugs, general anesthesia, woman
             undergoing her 3rd cesarean section or more, elective tubal ligation performed at the
             time of current cesarean section, contraindication for use of one or more of the
             studies' drugs.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Michal Kovo, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Wolfson Medical Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Lotem Dafna, MD</last_name>
    <phone>+972524205415</phone>
    <email>lotemdafne@yahoo.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Wolfson medical center</name>
      <address>
        <city>Holon</city>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rinat Hirsh</last_name>
      <phone>+97235028346</phone>
      <email>rinath@wmc.org.il</email>
    </contact>
    <investigator>
      <last_name>Lotem Dafna, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>June 2018</verification_date>
  <study_first_submitted>August 5, 2018</study_first_submitted>
  <study_first_submitted_qc>August 8, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">August 9, 2018</study_first_posted>
  <last_update_submitted>August 8, 2018</last_update_submitted>
  <last_update_submitted_qc>August 8, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">August 9, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acetaminophen</mesh_term>
    <mesh_term>Dipyrone</mesh_term>
    <mesh_term>Ibuprofen</mesh_term>
    <mesh_term>Morphine</mesh_term>
    <mesh_term>Tramadol</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

